QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide

Lancet

Volumn 355, Issue 9206, 2000, Pages 805-806

  Nakamae, Hirohisa ^a   Tsumura, Kei ^a   Hino, Masayuki ^a   Hayashi, Tomoshige ^a   Tatsumi, Noriyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; RANIMUSTINE;

ACUTE HEART FAILURE; ADOLESCENT; ADULT; ARTICLE; BLOOD DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD STEM CELL; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; RISK; STEM CELL TRANSPLANTATION;

EID: 0034603533     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02051-1     Document Type: Article

References (4)

1. GW Santos LL Sensenbrenner PJ Burke The use of cyclophosphamide for clinical marrow transplantation Trans Proc 4 1972 559 564
2. A Dritsa E Sbarouni D Giligan P Nihoyannopoulos C Oakley QT-interval abnormalities in hypertrophic cardiomyopathy Clin Cardiol 15 1992 739 742
3. P Herait N Poutigunat M Marty R Buget Early assessment of a new anticancer drug analogue: are the historical comparisons obsolete? The French experience with pirarubicin Eur J Cancer 28A 1999 1670 1676
4. B Sarubbi M Ordtiura V Dicceschi Ventricular repolarization time indexes following anthracycline treatment Heart Vessels 12 1997 262 266